Christophe Pouchoy, Managing Director and Chief Investment Officer of Trecento Asset Management, co-manager of the Trecento Santé fund, commented in Challenges magazine on the alliance between Sanofi and Abbott announced on September 16th, 2019 – the same day as the one between Novo Nordisk and Medtronic.
« Manufacturers are getting closer to medical equipment – sensors, insulin pumps – because accessing equipment is the guarantee of knowing and accessing the patient, (…) »
Read the article by clicking here (available in French only)